This retrospective study included 64 patients with LMD, with primary cancers represented in the diagnosis-specific Graded Prognostic Assessment (DS-GPA) at a single institution over 5 years.
Kaeli Samson, MA, MPH
Advertisement
Articles by Kaeli Samson, MA, MPH
Advertisement
Latest Updated Articles
Utility of the Diagnosis-Specific Graded Prognostic Assessment for Prognostication in Leptomeningeal DiseasePublished: May 15th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
3
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
4
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
5
